Skip to main content

I am immune to Covid-19, says Trump


US President Donald Trump on Sunday declared himself immune from Covid-19 as he prepares to return to the campaign trail in a fight to regain ground against surging White House rival Joe Biden.

"It looks like I'm immune for, I don't know, maybe a long time and maybe a short time, it could be a lifetime, nobody really knows, but I'm immune," Trump said in a Fox News interview, a day after his doctor affirmed he was


"You have a president who is immune... so now you have a president who doesn't have to hide in a basement like his opponent," he added -- in a jab at the Democrat Biden and his far more cautious approach to campaigning in a pandemic.

It is not yet clear to what degree contracting Covid-19 confers immunity from future infection, with early studies suggesting a few months while newer ones have indicated it could last longer


While it acknowledges that -- generally -- a person who recovers from a viral infection is protected against new infection, the World Health Organization cautioned in August: "For COVID-19, we do not yet have enough data to confirm if antibodies protect, what antibody levels are required, or how long protection will last."

During his phone interview on Fox News, Trump went on to suggest that his White House rival could himself be sick.


"If you look at Joe, he was coughing yesterday horribly and grabbing his mask, as he's coughing," Trump said. "And I don't know what that was all about, and it didn't get much press."

The Biden campaign has been publishing daily coronavirus tests for their candidate since Trump tested positive on October 1 -- landing him in hospital for three nights and derailing his campaign.

There has been less transparency surrounding Trump's own state of health, with his medical team repeatedly refusing to say when he lasted tested negative for the virus. That has fueled suspicions that he may not have been tested for several days prior to his diagnosis.

Trump rallied hundreds of supporters for a comeback event at the White House on Saturday, and is planning back-to-back rallies this week in a bit to salvage his struggling campaign three weeks from the November 3 election.

Comments

Popular posts from this blog

Iran, Russia Discussing Joint Production Of COVID-19 Vaccine

Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday. "We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying. Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.

Increased risks of drop out for women and girls : CoronaVirus Updates

The total number of children not returning to their education after the school closures is likely to be significant. The pandemic also risks jeopardizing some of the gains made since 2001 in re-building women and girls’ education following the Taliban regime.  The COVID-19 pandemic is creating additional barriers due to risks—and students’ and parents’ anxiety about risks—associated with children returning to classrooms that are cramped, with no capacity for distancing, often cold, damp and poorly ventilated during the country’s severe winters, and have no or poor hygiene and clean water facilities. The COVID-19 pandemic is likely to drive many women and girls out of education permanently. School closures due to COVID-19, resulting increases in caregiving responsibilities for women and girls, and increases in poverty and unemployment will all make it harder for women and girls to study.  These factors combine in harmful ways with pre-existing discriminatory gender norms, o...

Russia's Covid-19 vaccine Sputnik V available to public now: State media

First batches of Russia's Covid vaccine Sputnik V have entered "civil circulation" in capital Moscow, state media reported on Thursday. While details on the process were not immediately available, Russia has repeatedly stressed on producing the vaccine at the earliest, a belief met with international scepticism. Earlier this month, the Russian health ministry had said that batches of the Covid-19 vaccine were being produced for public distribution and would be supplied to different regions soon. "The first batch of the vaccine for preventing the novel coronavirus infection, Gam-COVID-Vac (Sputnik V) developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Health Ministry passed the required quality tests in the laboratories of Roszdravnadzor (the Federal Service for Surveillance in Healthcare) and was produced for civilian circulation. In the near future the supplies of the first batches of the vaccine to the regions are expected...